ArticleScientific reports2025
The prevalence of amblyopia and associated factors in older adults in The Malta Eye Study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
To assess amblyopia-related visual impairment in older Maltese adults and describe age-related trends in prevalence. The Malta Eye Study, a population-based, cross-sectional study, assessed a random stratified sample of adults aged 50-80 years. The examination involved a visual acuity test, autorefraction, slit-lamp examination, and a questionnaire related to demographics, ocular history, and the national eye institute visual function questionnaire. Statistical analysis of the visually impaired and amblyopic participants was performed, and associations with demographic and clinical variables were explored using stepwise multivariate logistic regression. Among 1794 participants aged 50 to 80 years, the prevalence of amblyopia-related visual impairment was 5.0% (95% CI 4.1-6.1%). The highest rates were observed in males, individuals aged 60-69 years, those with primary-level education, residents of the South-Eastern district, and individuals engaged in domestic work. When compared to individuals without visual impairment, only age 60-69 remained significantly associated in the final regression model (OR 2.2; 95% CI 1.2-4.1; p = 0.014). Anisometropia was the presumed cause of amblyopia in 50.6% of cases. Vision-related quality of life was mildly reduced in amblyopic individuals compared to non-visually impaired individuals. Amblyopia remains a cause of visual impairment among older adults in Malta, particularly those aged 60 + years, highlighting the irreversible visual and functional life-long impact of undetected childhood amblyopia and the need for early vision screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.